Search

everythinglearnresearchcommunity

for

Search:↓

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Effective treatments for severe alopecia areata are still lacking.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.